Swil-NewsWED · JUL 29 · 2026 · ISSUE № 2026.07.29
Same-day topicsGeneralFinance & marketsAI & techScience & researchCurrentCrypto & Web3Energy & climateAuto & mobilityGaming & entertainmentSupply chain & manufacturingSports, health & nutrition
Back to Science & researchBack to home

Jul 29, 2026 · Science & Research Daily Digest

Science, space, biomedical, and climate research highlights compiled for Jul 29, 2026, with summaries, links, and commentary.


I. Space & Deep Space

1. Zhurong finds primary evaporite in Utopia Planitia: evidence of substantial Amazonian aqueous activity (Space)

Summary:

Using Zhurong rover observations, a Chinese-led team identified a hydrous-mineral–rich platy rock layer on a ~0.76-Ga surface in southern Utopia Planitia and interpreted decimetre-scale crystal morphologies as euhedral selenite (a gypsum variety)—a primary evaporite signature. The paper was published in Nature Astronomy on July 29, 2026. Formation is estimated to require a cumulative water-equivalent column of at least ~6.25–25 m, plausibly from magmatically driven saline groundwater upwelling into a shallow, mostly ice-covered surface water body; large crystals may also host fluid inclusions that sample Amazonian subsurface chemistry and potential habitability.

Links:

Commentary:

Moving “recent liquid water on Mars” from inference to mineralogically identified primary evaporite refreshes assessments of Amazonian habitability windows.


2. NASA Roman Space Telescope pre-launch media briefing targets Aug. 30 Falcon Heavy liftoff (Space)

Summary:

NASA held a virtual news conference at 2:00 p.m. EDT on July 29 previewing the Nancy Grace Roman Space Telescope, with Astrophysics Division and Goddard project leads outlining mission status and science goals. The observatory has completed hydrazine fueling and is targeted for no earlier than Aug. 30 launch on a SpaceX Falcon Heavy from Kennedy Space Center LC-39A—about nine months ahead of schedule. Roman’s field of view is at least ~100× Hubble’s, enabling wide-field infrared surveys and a demonstration of advanced exoplanet direct-imaging technology.

Links:

Commentary:

The briefing marks Roman’s shift from integration into a public countdown—fairing encapsulation and final checkouts remain before dark-energy and exoplanet survey hardware flies.


3. NASA Moon Base lead: Korea a key partner; role-sharing among partners targeted within three months (Space)

Summary:

At a July 29 briefing in Seoul, NASA Moon Base program manager Carlos Garcia-Galan said the lunar base has entered Phase 1 and that partners must soon lock in transportation, foundational habitation, and the lunar terrain vehicle (LTV). He called talks with the Korea AeroSpace Administration (KASA) themselves evidence that Korea has risen to major-contributor status, aiming to define each partner’s direction and timeline in key areas within three months. The event previewed the July 30 KASA–NASA Artemis Workshop covering landers, communications, surface vehicles, and science exploration.

Links:

Commentary:

Artemis is shifting from landing demos to permanent-infrastructure workshares—the partner role list will shape the 2029–2032 south-pole base engineering path.


II. Biomedicine

4. KinoPlex structural atlas decodes kinase specificity across the human proteome (Biomedicine)

Summary:

Vanderwall, Huttlin, Mintseris and colleagues published an AI-enabled KinoPlex framework in Nature Biotechnology on July 29, 2026, integrating ~20,000 AlphaFold models with kinase recognition motifs to score phosphorylation potential and kinase specificity for ~1.8 million Ser/Thr/Tyr residues. They identified ~567,000 structurally phospho-competent sites and ~250,000 high-confidence candidates. The atlas introduces “sequence–structure selective coupling,” whereby kinase specificity can arise from structural scarcity (negative-selecting) or accessibility (positive-selecting) of preferred motifs—not motif discrimination alone. Deep phosphoproteomics in K562 cells validated predictions.

Links:

Commentary:

Moving phosphorylation from sequence catalogs to structural-accessibility maps could reorder kinase drug-target priorities and mechanism interpretation.


5. Base editing rewires huntingtin processing: Huntington’s symptoms ease in mice (Biomedicine)

Summary:

University of Illinois Urbana-Champaign teams led by Pablo Perez-Pinera and Thomas Gaj report in Nature Biomedical Engineering that, after screening 140+ base editors, injecting optimal editors into brains of mice with mutant HTT caused cells to skip a huntingtin segment prone to toxic fragments while retaining enough protein for normal function. Treated mice showed less toxic-fragment buildup, reduced symptoms, and less brain degeneration. News-Medical covered the work on July 29; authors stress the approach differs from fully shutting the gene off.

Links:

Commentary:

“Fine-tuning processing” rather than “hard-silencing the protein” opens a third gene-therapy logic for an incurable disease—human translation and off-target risk remain the next gates.


Summary:

An international team co-led by Fred Hutch, Sinai Health, and the University of Helsinki analyzed genetic data from more than 2.5 million adults in Nature Medicine, identifying 26 fibromyalgia-associated variants. The strongest signal sits in HTT—the Huntington’s disease gene—with another at GPR52, which regulates HTT levels. Integration with a ~20-million-cell expression atlas showed risk-neighbor genes more active in nervous-system cells than in classical autoimmune tissues. Fred Hutch’s release is dated July 28, 2026; authors call this the strongest evidence yet that fibromyalgia is primarily a nervous-system disorder, while noting genetics alone is insufficient without triggers.

Links:

Commentary:

Genome-scale biology anchors a long-contested chronic-pain syndrome and hints that Huntington’s-pathway nodes may be shared, drug-accessible targets.


7. FDA CTGTAC reviews Capricor’s Deramiocel for Duchenne cardiomyopathy (Biomedicine)

Summary:

The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee met on July 29, 2026, to discuss Capricor’s BLA 125842 for Deramiocel (allogeneic cardiosphere-derived cells) for cardiomyopathy in Duchenne muscular dystrophy. Pre-meeting FDA briefing materials questioned whether Phase 3 HOPE-3 provides substantial evidence of effectiveness and flagged hypersensitivity risks; Capricor emphasizes skeletal and cardiac benefits across studies. The PDUFA target action date is August 22, 2026; committee advice is non-binding.

Links:

Commentary:

Rare-disease cell therapy is at a hard collision between sponsor endpoint narratives and regulator statistical frames—discussion before Aug. 22 will reshape DMD pipeline expectations.


8. TScan doses first patient in pivotal Phase 3 ALLOHA-2 for TCR-T therapy TSC-101 (Biomedicine)

Summary:

On July 29, 2026, TScan Therapeutics announced the first patient in pivotal Phase 3 ALLOHA-2 (NCT07702578) received TSC-101 after successful allogeneic hematopoietic cell transplant engraftment. The trial evaluates the TCR-engineered T-cell therapy for residual disease to prevent relapse in AML and MDS post–allo-HCT; the primary endpoint is relapse-free survival, with key secondary endpoints of overall and event-free survival. The treatment arm is planned for two infusions after engraftment.

Links:

Commentary:

First pivotal dosing moves TCR-T relapse prevention from concept into the evidence-generation phase that can decide a registration path.


III. Climate & Environment

9. China releases National Climate Change 15th Five-Year Plan: 17% further carbon-intensity cut (Climate)

Summary:

On July 29, China’s Ministry of Ecology and Environment, with the Ministry of Foreign Affairs, NDRC and other agencies, released the National Climate Change Plan for the 15th Five-Year period. Targets include cutting CO₂ emissions per unit of GDP by 17% by 2030 versus 2025; reducing CO₂ per unit of product in carbon-market–covered industries by ~3% versus 2025; and strengthening non-CO₂ greenhouse-gas monitoring and control to form 30 million tonnes CO₂-equivalent mitigation capacity. The plan elevates non-CO₂ gases into a dedicated chapter and advances carbon-footprint systems, voluntary markets, and climate adaptation.

Links:

Commentary:

Locking the tail-end intensity target together with non-CO₂ control marks a shift from a single peaking narrative to multi-gas coordinated governance.


10. UCLA–Ewha: mixed plastics to high-purity hydrogen via ATT—no sorting required (Environment)

Summary:

UCLA and Ewha Womans University researchers adapted alkaline thermal treatment (ATT; NaOH-catalyzed) to mixed PET, PE, and PP waste, yielding hydrogen at >90% purity in a single reactor without sorting. The process runs ~300–400°C cooler than conventional gasification and captures ~75% of carbon byproducts as solids rather than CO₂. Chemically inert PE/PP receive a thermal-oxidation pretreatment to add oxygenated groups. Results appear in PNAS; ScienceAlert and others followed on July 29. Authors note commercial scale-up and emission optimization still need work.

Links:

Commentary:

Hitting both sorting cost and lower-temperature hydrogen in one scheme is compelling—but lab samples to continuous industrial operation remains a large engineering gap.


11. Satellite TIR quantifies U.S. dam effects on river temperature: changes in 71% of profiles (Environment)

Summary:

Virginia Tech’s George Allen, Emily Ellis and colleagues used Landsat thermal infrared imagery to quantify upstream–downstream river surface temperature differences at 287 large U.S. dams (2013–2024), publishing in Science Advances. About 71% of longitudinal profiles showed downstream thermal change—typically warmer (~60%), averaging ±0.7–1.4°C—and many changes persisted or intensified within 20 km; reservoir dams accounted for 91% of extreme (≥±4°C) differences. Caixin and others covered ecological implications on July 29, including risks to cold-water fish spawning windows.

Links:

Commentary:

Scaling dam “thermal fingerprints” from case studies to a national baseline gives hydropower operators and fisheries managers an actionable remote-sensing tool.


IV. Fundamental Research

12. High-entropy sulfide photocatalyst enables cascade C–N coupling: 91.7% imine selectivity (Chemistry)

Summary:

Yang and colleagues report in Nature Communications on July 29, 2026, a high-entropy sulfide photocatalyst (NiSnCaZnInS) that drives collaborative cascade C–N coupling of biomass-derived benzyl alcohol with NH₃ to valuable imines: ~1240 μmol g_cat⁻¹ over 5 hours at 91.7% selectivity. Performance is attributed to multifunctional sites on the high-entropy surface. The light-driven route offers a renewable-powered alternative for converting biomass alcohols into nitrogen-containing chemicals.

Links:

Commentary:

High-entropy materials move from structural novelty to multi-site tandem catalysis—selectivity looks strong; durability and substrate scope are next.


13. Smith-hat monotile structures show chiral diffraction: math puzzle yields new optics (Physics)

Summary:

A University of Tokyo Institute of Industrial Science team led by Masaya Notomi fabricated nanoscale patterns based on the Smith hat—the monotile that solves the “Einstein problem” of aperiodic monohedral tiling—on silicon nitride films via electron-beam lithography. Laser illumination produced pinwheel-like chiral diffraction patterns not seen in conventional quasicrystals; response depended on incident direction and polarization, with real-space mirrors reversing optical behavior. Phys.org covered the Nature Communications work around July 29, 2026.

Links:

Commentary:

Pure tiling mathematics unexpectedly opens polarization-controllable optics—another short path from abstract math to device physics.


14. Quantum bath autonomously entangles distant qubits: 20-year theory confirmed (Physics)

Summary:

ISTA’s Andrés-Juanes, Fink and collaborators (with TU Munich) used a Josephson parametric converter to create a two-mode-squeezed microwave “quantum bath” that autonomously synchronized two transmon qubits over ~50 cm of coaxial cable—without active feedback or repeated measurements—experimentally confirming a ~20-year-old prediction. The work appears in Physical Review X; ScienceAlert covered it on July 29. The team reports transferring ~10% of the bath’s available entanglement so far; active-control schemes remain more efficient, but the framework is scalable to multi-qubit sync.

Links:

Commentary:

Passive bath synchronization offers another architecture for distributed quantum computing—the efficiency gap is engineering; conceptual autonomy is the real breakthrough.


Today's Summary

  • Space: Zhurong’s primary evaporite revises Amazonian water activity; Roman enters pre-launch briefing; U.S.–Korea Moon Base role-sharing enters a three-month clock.
  • Biomedicine: KinoPlex, Huntington’s base editing, and fibromyalgia genetics showcase structure/AI, gene editing, and genomics toolkits; Deramiocel’s adcomm and TScan’s Phase 3 first dose mark parallel translation nodes.
  • Climate & environment: China’s 15th Five-Year climate plan elevates non-CO₂ control; plastic-to-hydrogen ATT and dam–river thermal studies press circular and ecological infrastructure narratives.
  • Fundamentals: High-entropy photocatalysis, monotile chiral optics, and quantum-bath entanglement keep materials, math, and quantum information producing testable prototypes.

Daily Framing:

Today in the science cycle was a “deep-space water evidence and launch-countdown meets proteome/gene-editing toolkits, with climate policy and circular tech advancing in parallel” day—discovery, engineering deadlines, and regulatory review stacked on the same date.


This digest is compiled from real-time search results and is for reference only.

MORE FROM SCIENCE & RESEARCH

Aug 23, 2026

Aug 23, 2026 · Science & Research Daily Digest

Science, space, biomedicine, and climate research highlights compiled for Aug 23, 2026, with summaries, links, and commentary.
Aug 22, 2026

Aug 22, 2026 · Science & Research Daily Digest

A digest of today's science, space, biomedicine, and climate research news for Aug 22, 2026, with summaries, links, and commentary.
Aug 21, 2026

Aug 21, 2026 · Science & Research Daily Digest

A roundup of today’s science, space, biomedicine, and climate research headlines for Aug 21, 2026, with summaries, links, and brief commentary.